Editorial: Current Challenges and Future Perspectives on Emerging Bioelectrochemical Technologies

Editorial: Current Challenges and Future Perspectives on Emerging Bioelectrochemical Technologies

In its simplest form, bioelectrochemical systems (BESs) consist of an anode, a cathode, and a microbial catalyst (Rabaey and Rozendal, 2010). One of the attractive features of bioelectrochemical technology is that, BESs can be developed to implement anodic-based or cathodic-based bioprocesses or both at the same time. For example, pollutants can be degraded by a specialized microbial catalyst a...

Down Syndrome: Current Status, Challenges and Future Perspectives

Down syndrome (DS) is a birth defect with huge medical and social costs, caused by trisomy of whole or part of chromosome 21. It is the most prevalent genetic disease worldwide and the common genetic cause of intellectual disabilities appearing in about 1 in 400-1500 newborns. Although the syndrome had been described thousands of years before, it was named after John Langdon Down who described ...

down syndrome: current status, challenges and future perspectives

down syndrome (ds) is a birth defect with huge medical and social costs, caused by trisomy of whole or part of chromosome 21. it is the most prevalent genetic disease worldwide and the common genetic cause of intellectual disabilities appearing in about 1 in 400-1500 newborns. although the syndrome had been described thousands of years before, it was named after john langdon down who described ...

Editorial: Emerging Perspectives on System-of-Systems

Challenges in IPF diagnosis, current management and future perspectives.

Recent developments have clarified our understanding of IPF and improved outcomes with two viable new therapeutic options, pirfenidone and nintedanib. In spite of these advances, questions and challenges concerning IPF still remain. Here we will focus on some of these unresolved areas: the diagnosis of IPF is hindered by limitations in current practice guidelines, surgical lung biopsy is contra...